Together with other lung resident cells expressing IL-17RB, it is believed that IL-25 is highly contributed to the inflammation and lung damage via its direct action on lung endothelial cells, antigen presenting cells and Th2-related immune cells during asthma progression (8, 17–19). This evidence concerns the gene IL17RB and asthma.